AR882 is an investigational selective uric acid transporter 1 inhibitor. The Food and Drug Administration (FDA) has granted Fast Track designation to AR882 for the treatment of clinically visible ...
SINGAPORE and PRINCETON, N.J., July 25, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced that FDA has designated its ...
If you suffer from gout, you know that flare-ups are uncomfortable and distressing. Symptoms like sudden pain, inflammation, and sensations of heat can turn a good day into a difficult one. If you're ...
ALLN-346 is an investigational, first-in-class, nonabsorbed, orally-administered enzyme that breaks down urate in the gastrointestinal tract. The Food and Drug Administration (FDA) has granted Fast ...
NEWTON, Mass., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) (“Allena” or the “Company”), a late-stage biopharmaceutical company deploying its novel oral biologic ...
ALLN-346 is an investigational, first-in-class, nonabsorbed, orally-administered enzyme that breaks down urate in the gastrointestinal tract. The Food and Drug Administration (FDA) has granted Fast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback